A comprehensive view of Phase 1 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Cybin’s New Drug Application for clinical trial evaluating oral CYB003 deuterated psilocybin analog to treat major depressive disorder; drug is first novel psilocybin analog to start clinical development, with Phase1/2a trial starting soon

Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes

Merck reports experimental injectable pneumococcal vaccine V116 met primary immunogenicity objectives in Phase 1-2 study; vaccine targets 21 strains of Streptococcus pneumoniae that cause 85% of pneumonia cases in adults 65 years and over in US

Galderma Research & Development announces Phase 1 clinical trial to compare rate, extent of absorption of single dose of nemolizumab administered with auto-injectors versus dual-chamber syringes; recruitment for study has not yet started

Legend Biotech receives FDA approval for Phase 1 clinical trial in US of T-cell therapy LB190 to treat gastric, esophageal, pancreatic cancers; in US, 123,920 people have stomach cancer, 49,084 have esophageal cancer, 89,248 have pancreatic cancer

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count